| P2093 | author name string | Hiroshi Abe | |
| | Tomonori Sugita | |
| | Yoshio Aizawa | |
| | Akihiko Sakata | |
| | Kazuhiko Fujiki | |
| | Toru Asano | |
| | Yohei Furumoto | |
| | Yoshimichi Chuganji | |
| P2860 | cites work | Type 1 autoimmune hepatitis in Turkish patients: absence of association with HLA B8. | Q53311936 |
| | Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India. | Q54682881 |
| | Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. | Q54796237 |
| | Autoimmune Hepatitis | Q56210456 |
| | Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus | Q58852133 |
| | Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2 | Q58852141 |
| | Significance of HLA DR4 in type 1 autoimmune hepatitis | Q72566297 |
| | Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre | Q80087406 |
| | HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients | Q80352996 |
| | Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly | Q82640069 |
| | Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood | Q83925756 |
| | Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4 | Q83951385 |
| | Treatment of autoimmune hepatitis | Q84395796 |
| | Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis | Q93910045 |
| | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 |
| | Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients | Q33869526 |
| | Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors | Q34094790 |
| | Autoantibodies and autoantigens in autoimmune hepatitis | Q34160580 |
| | Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis | Q34402274 |
| | Genetic distinctions between autoimmune hepatitis in Italy and North America | Q34406835 |
| | The validity and importance of subtypes in autoimmune hepatitis: a point of view | Q36690069 |
| | Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis | Q40536266 |
| | Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis | Q43186281 |
| | Autoimmune hepatitis with acute presentation in Japan | Q43447963 |
| | Diagnosis and treatment of autoimmune hepatitis | Q44080061 |
| | Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 |
| | Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. | Q44100194 |
| | Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis | Q45057464 |
| | Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. | Q45963125 |
| | Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis | Q46847236 |
| | Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis | Q46923672 |
| | Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. | Q50628941 |
| | Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. | Q50948422 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 144 | |
| P577 | publication date | 2015-10-21 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis | |
| P478 | volume | 15 | |